Eden Research plc (EDEN) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
Business summary
Eden Research plc is a United Kingdom-based company, which is focused on biopesticides for sustainable agriculture. The Company develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products are formulated with terpene active ingredients, based on natural plant defense metabolites. Its product portfolio includes Mevalone and Cedroz. Mevalone is a foliar biofungicide, which targets a key disease affecting grapes and other high-value fruit and vegetable crops. Cedroz is a bionematicide that targets free-living nematodes, which are parasitic worms that affect a range of high-value fruit and vegetable crops globally. The Company's Sustaine encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease of use.
Contact details
Important dates
General stock information
- EPIC:
- EDEN
- ISIN:
- GB0001646941
- Market cap:
- £21.07 million
- Shares in issue:
- 533.35 million
- Sector:
- Pharmaceuticals & Biotechnology
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.